Serum protein panel test can help identify cardiomyopathy risk in childhood cancer survivors
Findings from scientists at St. Jude Children's Research Hospital are showing promise for assessing cardiomyopathy risk in childhood...
Dec 11, 2024
UCalgary researchers help preserve future fertility options for children impacted by cancer
University of Calgary researchers are giving children and adolescents whose fertility may be impacted by cancer, or treatments associated...
Dec 10, 2024
How a Penn State professor developed a cancer-fighting drug for kids
Giselle Saulnier Sholler has spent 20 years working treatments for neuroblastoma, a particularly aggressive form of early childhood...
Dec 6, 2024
New insights into risk assessment of rare, aggressive tumors in children
An international research team including researchers from Augsburg University Medicine has made significant progress in the risk...
Dec 3, 2024
CNIO opens up new research pathways against paediatric cancer Ewing sarcoma by discovering mechanisms that make it more aggressive
A new study led by Ana Losada, head of the Chromosomal Dynamics Group at Spain’s National Cancer Research Centre (CNIO), identifies...
Nov 29, 2024
Larotrectinib Is Promising for Pediatric TRK Fusion-Positive CNS Tumors
Larotrectinib led to rapid/durable responses and high disease control rates in children with TRK fusion-position central nervous system...
Nov 28, 2024
Researchers identify gene signature for high-risk form of T-cell acute lymphoblastic leukemia
Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset of patients...
Nov 27, 2024
If My Dying Daughter Could Face Her Mortality, Why Couldn’t the Rest of Us?
"In pediatric cancer care, which has an understandable emphasis on cure, advances that have brought families hope can often mean survival...
Nov 26, 2024
FDA Grants Rare Pediatric Designation to Elraglusib for Ewing Sarcoma
The FDA granted a rare pediatric disease designation to elraglusib (9-ING-41), a novel GSK-3β inhibitor, as a potential therapeutic...
Nov 18, 2024
Self-reported screening can reduce distressing symptoms for pediatric patients with cancer
Regular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients...
Nov 15, 2024